Recent studies revealed a direct negative feedback loop between miR-203a and ZEB2 participating in tumor stemness and chemotherapy resistance, in which increased miR-203a expression sensitized cancer cells to cisplatin in vitro [33,34]. This evidence concerns the gene ZEB2 and neoplasm.